{"classes":[{"categories":[{"measurements":[{"groupId":"OG000","lowerLimit":"40.7","upperLimit":"267.1","value":"176.14"},{"groupId":"OG001","lowerLimit":"7.4","upperLimit":"239.3","value":"45.00"},{"groupId":"OG002","lowerLimit":"2.9","upperLimit":"146.1","value":"28.64"},{"groupId":"OG003","lowerLimit":"9.1","upperLimit":"265.1","value":"59.21"},{"groupId":"OG004","lowerLimit":"6.6","upperLimit":"255.1","value":"69.29"},{"groupId":"OG005","lowerLimit":"22.7","upperLimit":"238.3","value":"66.64"},{"groupId":"OG006","lowerLimit":"12.1","upperLimit":"209.1","value":"43.57"},{"groupId":"OG007","lowerLimit":"42.71","upperLimit":"42.71","value":"42.71"},{"groupId":"OG008","lowerLimit":"8.0","upperLimit":"80.1","value":"32.79"},{"groupId":"OG009","lowerLimit":"17.0","upperLimit":"123.1","value":"104.71"},{"groupId":"OG010","lowerLimit":"21.0","upperLimit":"77.3","value":"52.14"}]}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"3"},{"groupId":"OG001","value":"29"},{"groupId":"OG002","value":"28"},{"groupId":"OG003","value":"24"},{"groupId":"OG004","value":"17"},{"groupId":"OG005","value":"10"},{"groupId":"OG006","value":"4"},{"groupId":"OG007","value":"1"},{"groupId":"OG008","value":"14"},{"groupId":"OG009","value":"16"},{"groupId":"OG010","value":"71"}],"units":"Participants"}],"description":"Duration of response is defined as time from the earliest date of documented response (PR or better) to the earliest date of disease progression per IMWG Uniform Response Criteria or death, whichever occurred first. Participants who do not have progression of disease or death will be censored on the last adequate response assessment date. Duration of response for responders will be summarized using Kaplan-Meier estimates by cohort and dose level as appropriate.\n\nData will be collected and analyzed per Cohort Totals.","dispersionType":"Full Range","groups":[{"description":"CC220","id":"OG000","title":"Cohort A: Total"},{"description":"CC220 + DEX","id":"OG001","title":"Cohort B: Total"},{"description":"CC220","id":"OG002","title":"Cohort D: Total"},{"description":"CC220 + DARA + DEX","id":"OG003","title":"Cohort E: Total"},{"description":"CC220 + BORT + DEX","id":"OG004","title":"Cohort F: Total"},{"description":"CC220 + CFZ + DEX","id":"OG005","title":"Cohort G: Total"},{"description":"CC220 + DEX","id":"OG006","title":"Cohort H1"},{"description":"CC220 + DEX","id":"OG007","title":"Cohort H2"},{"description":"CC220 + DEX","id":"OG008","title":"Cohort I"},{"description":"CC220 + NE-ASCT","id":"OG009","title":"Cohort J: Total"},{"description":"CC220 + DARA + DEX","id":"OG010","title":"Cohort K"}],"paramType":"MEDIAN","populationDescription":"Safety Population - As per protocol, DOR and PFS will combine arms in the cohort for endpoint presentation","reportingStatus":"POSTED","timeFrame":"On Average of (Cohort A:161.33, Cohort B: 63.74, Cohort D: 39.16, Cohort E: 89.56, Cohort F: 69.24, Cohort G: 80.93, Cohort H1: 77.11, Cohort H2: 42.71, Cohort I: 36.80, Cohort J: 92.36, Cohort K: 51.85) Weeks","title":"Duration of Response","type":"SECONDARY","unitOfMeasure":"Weeks"}